News

Explore the news, insights and scientific results that tell the story of Ulysses Biomed's evolution: between molecular innovation, regulated markets and strategic vision.

Topic

Updates and announcements
Press releases
Insights
Scientific publications

Updates and announcements

View All

24 June 2026

Helyx Industries in the public hospital channel: two awards in oncohematology

08 June 2026

Subsidiary Hyris awarded a public tender in Spain for the supply of SARS-CoV-2 cellular-immunity kits within a public research project

18 May 2026

Helyx Industries granted U.S. patent for its proprietary deep multiplexing technology

11 May 2026

Helyx Industries Files International Patent Application for a Smart Remote Calibration Device for HYRIS bCUBE™

Price sensitive press releases

See all price sensitive press releases

10 July 2026

Global Corporate Finance LLC sottoscrive la seconda tranche di aumento di capitale in esecuzione dell’accordo di investimento sottoscritto in data 31 luglio 2025

30 June 2026

"Warrant Helyx Industries S.p.A. 2021-2026": risultati del nono periodo di esercizio

29 May 2026

Apertura del nono periodo di esercizio dei "Warrant Helyx Industries S.p.A. 2021-2026" dal 1 al 30 giugno 2026

26 May 2026

Integrae SIM avvia la copertura sul titolo

Insights

See all insights

10 September 2026 | Distributed Diagnostics

Distributed PCR: building the business case for a hybrid network

Distributed PCR does not eliminate cost: it reallocates it. A credible business case compares complete workflows, transferred costs, quality, utilisation and decisions from a stated perspective.

31 August 2026 | Biotech and Diagnostic Innovation

PCR and artificial intelligence in infectious diseases: where clinical value may emerge

AI can analyse curves, monitor processes and connect PCR results; its value depends on intended purpose, external validation, human oversight and transparent management of updates.

20 August 2026 | Biotech and Diagnostic Innovation

Portable PCR: when can the laboratory truly move?

PCR becomes truly portable when the sample, biosafety, power, operator, data and decision-making work together in the intended context, not when only the instrument is made smaller.

10 August 2026 | Market and Industry Trends

Longevity and molecular diagnostics: when a biomarker can guide a decision

A biomarker supports prevention when the measurement is reliable, adds information beyond the standard of care and changes a decision within a defined clinical pathway.

Scientific publications

See all scientific publications

07 August 2025

The Use of Self-Sampling Devices via a Smartphone Application to Encourage Participation in Cervical Cancer Screening: A Pilot Study

23 April 2025

Off-grid field-deployable molecular diagnostic platform for malaria surveillance

08 April 2025

Rapid, Single-Step Monitoring of Monoclonal Antibody Bioavailability by Using a TNF-α-Based Multiepitope DNA Nanoswitch

13 June 2022

Instruments

Software Solutions

Reagents

Vision & Values

Numbers and Certifications

Leadership

About Helyx

Distributed PCR: building the business case for a hybrid network

PCR and artificial intelligence in infectious diseases: where clinical value may emerge

Press releases

Press releases

Updates and announcements

Updates and announcements

Investors

Instruments

Software Solutions

Reagents

Vision & Values

Numbers and Certifications

Leadership

About Helyx

Updates & announcements

Press releases

Scientific Publications

Helyx Industries

News

Explore the news, insights and scientific results that tell the story of Ulysses Biomed's evolution: between molecular innovation, regulated markets and strategic vision.

Topic

Updates and announcements

Helyx Industries in the public hospital channel: two awards in oncohematology

Subsidiary Hyris awarded a public tender in Spain for the supply of SARS-CoV-2 cellular-immunity kits within a public research project

Helyx Industries granted U.S. patent for its proprietary deep multiplexing technology

Helyx Industries Files International Patent Application for a Smart Remote Calibration Device for HYRIS bCUBE™

Price sensitive press releases

Global Corporate Finance LLC sottoscrive la seconda tranche di aumento di capitale in esecuzione dell’accordo di investimento sottoscritto in data 31 luglio 2025

"Warrant Helyx Industries S.p.A. 2021-2026": risultati del nono periodo di esercizio

Apertura del nono periodo di esercizio dei "Warrant Helyx Industries S.p.A. 2021-2026" dal 1 al 30 giugno 2026

Integrae SIM avvia la copertura sul titolo

Insights

Distributed PCR: building the business case for a hybrid network

PCR and artificial intelligence in infectious diseases: where clinical value may emerge

Portable PCR: when can the laboratory truly move?

Longevity and molecular diagnostics: when a biomarker can guide a decision

Scientific publications

The Use of Self-Sampling Devices via a Smartphone Application to Encourage Participation in Cervical Cancer Screening: A Pilot Study

Off-grid field-deployable molecular diagnostic platform for malaria surveillance

Rapid, Single-Step Monitoring of Monoclonal Antibody Bioavailability by Using a TNF-α-Based Multiepitope DNA Nanoswitch

Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR